Literature DB >> 3248029

[Plasma PGE2, TXB2 and 6-keto PGF1 alpha levels in patients with Kawasaki disease].

K Sasai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3248029

Source DB:  PubMed          Journal:  Arerugi        ISSN： 0021-4884


× No keyword cloud information.
  3 in total

1.  Salicylate treatment in Kawasaki disease: high dose or low dose?

Authors:  T Akagi; H Kato; O Inoue; N Sato
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

2.  Identification of rare coding variants associated with Kawasaki disease by whole exome sequencing.

Authors:  Jae-Jung Kim; Young Mi Hong; Sin Weon Yun; Kyung-Yil Lee; Kyung Lim Yoon; Myung-Ki Han; Gi Beom Kim; Hong-Ryang Kil; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Hyun Ok Jun; Byung-Ok Choi; Yeon-Mok Oh; Jeong Jin Yu; Gi Young Jang; Jong-Keuk Lee
Journal:  Genomics Inform       Date:  2021-12-31

3.  Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.

Authors:  Ho-Chang Kuo; Chih-Lu Wang; Kuender D Yang; Mao-Hung Lo; Kai-Sheng Hsieh; Sung-Chou Li; Ying-Hsien Huang
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.